Greenfield Hightech-Plasmafraktionierungsanlage in der Türkei

Chemgineering International GmbH, an international ‘design & build’ partner for life science projects, is the EPCMV service provider for Maxicells ‘New blood plasma fractionation plant’ in Turkey. Maxicells, in collaboration with the Turkish Red Crescent, further aims to domestically produce plasma products from domestic blood plasma, and to consequently ensure that Turkey becomes a self-sufficient country in terms of producing.

plasma products. Maxicells has set out to produce specific blood products that have already been manufactured by a few centers in the world, however not yet been produced in Turkey. Therefore, the design -as well as the construction have already been started to build the very first biological production facility for blood plasma.

products in Turkey. The facility will produce 4 main plasma products (Immunoglobulin, Albumin, and the coagulation factors F-VIII and F-IX) as finished products in various sizes and concentrations. These drugs are used to treat e.g. hemophilia, certain infections, rheumatoid arthritis, leukemia and other immune system diseases, and will be made available nationwide for all patients in Turkey.

The project in brief:

– Greenfield, located in Silivri (nearby Istanbul)
– About 10 hectares of land
– Processing ~650.000 liter plasma / year
– Extendable to ~1 Mio liter/year
– Facility consisting of 3 main buildings, plus several supporting buildings and structures
– Gross building area ~50.000 m²
– Total Investment Costs ~600 Mio €
– Extended Basic Design (EBD) within 12 months
– Building permits and start of construction works 6 months after start of the EBD
– Building shell of ~50.000 m² erected within 6 months from groundbreaking
– A cross-trade team from Chemgineering, in cooperation with a result-orientated and highly professional Maxicells-Team, allowed to achieve this extraordinary project progress in a challenging environment.

A cross-trade team from Chemgineering, in cooperation with a result-orientated and highly professional Maxicells-Team, allowed to achieve this extraordinary project progress in a challenging environment.

The Chemgineering Group is an international consulting and planning company focusing on highly regulated industries such as pharmaceuticals, biotechnology, fine chemicals and medical technology. From GxP-Consulting to concept studies and turnkey solutions, it offers the full range of services. With more than 400 highly qualified employees at 19 locations in Switzerland, Germany, Austria, Serbia, Spain, Poland and Mexico, Chemgineering is the preferred partner for many multinational and local companies.